HK1098356A1 - 用於哮喘和copd长期治疗的抗胆硷能药和糖皮质激素的组合 - Google Patents
用於哮喘和copd长期治疗的抗胆硷能药和糖皮质激素的组合 Download PDFInfo
- Publication number
- HK1098356A1 HK1098356A1 HK07104757.8A HK07104757A HK1098356A1 HK 1098356 A1 HK1098356 A1 HK 1098356A1 HK 07104757 A HK07104757 A HK 07104757A HK 1098356 A1 HK1098356 A1 HK 1098356A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- glycopyrrolate
- asthma
- copd
- acceptable salt
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54195604P | 2004-02-06 | 2004-02-06 | |
US60/541,956 | 2004-02-06 | ||
PCT/EP2005/000652 WO2005074918A1 (en) | 2004-02-06 | 2005-01-24 | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1098356A1 true HK1098356A1 (zh) | 2007-07-20 |
HK1098356B HK1098356B (en) | 2010-08-13 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
ES2413011T3 (es) | 2013-07-15 |
WO2005074918A1 (en) | 2005-08-18 |
DK1713473T3 (da) | 2013-06-17 |
CA2551780C (en) | 2013-02-26 |
AU2005210085B2 (en) | 2010-06-24 |
CN1913883A (zh) | 2007-02-14 |
NZ548300A (en) | 2010-04-30 |
NO336882B1 (no) | 2015-11-23 |
JP4819699B2 (ja) | 2011-11-24 |
AU2005210085A1 (en) | 2005-08-18 |
RU2006132038A (ru) | 2008-03-20 |
NO20063879L (no) | 2006-11-01 |
US20080300226A1 (en) | 2008-12-04 |
EP1713473A1 (en) | 2006-10-25 |
RU2440813C2 (ru) | 2012-01-27 |
EP1713473B1 (en) | 2013-03-13 |
PL1713473T3 (pl) | 2013-08-30 |
PT1713473E (pt) | 2013-05-13 |
JP2007520508A (ja) | 2007-07-26 |
CA2551780A1 (en) | 2005-08-18 |
CN100569235C (zh) | 2009-12-16 |
US10537550B2 (en) | 2020-01-21 |
US20050175548A1 (en) | 2005-08-11 |
SI1713473T1 (sl) | 2013-06-28 |
HRP20130460T1 (hr) | 2013-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10537550B2 (en) | Methods of treating underlying inflammation from COPD or asthma | |
JP2020023537A (ja) | Copdの治療のためのチオトロピウムブロミド、フォルモテロール及びブデソニドの組み合わせ | |
EP2207538A1 (en) | Compositions comprising cetirizine and a non beta-2-adrenoreceptor agonist, a beta-2-adrenoreceptor agonist or an anti -inflammatory and the use thereof for the treatment of respiratory disorders | |
US20140329782A1 (en) | Combined therapeutic agent | |
Hsieh et al. | Comparative efficacy and tolerability of beclomethasone/formoterol and fluticasone/salmeterol fixed combination in Taiwanese asthmatic patients | |
US20220218672A1 (en) | Thromboxane Receptor Antagonists in AERD/Asthma | |
KR20180119597A (ko) | 염증 상태의 급성 악화의 치료를 위한 투약법 | |
AU2003292120B2 (en) | New synergistic combination comprising roflumilast and formoterol | |
HK1098356B (en) | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd | |
MXPA06008938A (en) | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd | |
JP5220741B2 (ja) | アンドラスト/グルココルチコイドの併用 | |
Yerbury et al. | 3 Symptom Management | |
Connolly | Drugs and the Lung—COPD, Asthma, Interstitial Lung Disease | |
JP2013056925A (ja) | アンドラスト/グルココルチコイドの併用 | |
HK1232788A1 (en) | Combinations of tiotropium bromide, formoterol and budesonide for the treatment of copd | |
HK1087009A1 (en) | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients | |
HK1087009B (en) | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220126 |